Allspring Global Investments
IBB icon

Allspring Global Investments’s iShares Biotechnology ETF IBB Stock Holding History

Allspring Global Investments’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.15M Sell
32,336
-20,195
-38% -$3.47M 0.01% 844
2026
Q1 		$8.94M Buy
52,531
+5,625
+12% +$962K 0.02% 724
2025
Q4 		$7.93M Buy
46,906
+46,806
+46,806% +$7.6M 0.01% 755
2025
Q3 		$14.4K Buy
+100
New +$13.7K ﹤0.01% 1615

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Allspring Global Investments's IBB Position: Q2 2026 in Review

Allspring Global Investments reduced its iShares Biotechnology ETF (IBB) stake by 38% in Q2 2026, selling an estimated $3.47M and leaving 32,336 shares worth $6.15M. The position accounts for 0.01% of the portfolio, ranked #844.

Allspring Global Investments first reported a position in IBB in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.94M in Q1 2026. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Allspring Global Investments held 32,336 shares of iShares Biotechnology ETF worth $6.15M as of Q2 2026.
  • Allspring Global Investments sold 20,195 iShares Biotechnology ETF shares in Q2 2026, an estimated $3.47M.
  • iShares Biotechnology ETF made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #844 holding.
  • Allspring Global Investments first reported a position in iShares Biotechnology ETF in Q3 2025 and has held it in 4 quarters since.
  • Allspring Global Investments's iShares Biotechnology ETF position peaked at $8.94M in Q1 2026.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.